Advertisement

Inflammopharmacology

, Volume 24, Issue 6, pp 377–388 | Cite as

Curcuma longa extract reduces inflammatory and oxidative stress biomarkers in osteoarthritis of knee: a four-month, double-blind, randomized, placebo-controlled trial

  • Shobhit Srivastava
  • Anil K. SaksenaEmail author
  • Sanjay Khattri
  • Santosh Kumar
  • Raghubendra Singh Dagur
Original Article

Abstract

Background and purpose

Curcuma longa L. (CL), an Indian herb, has been used to treat many disorders because of its wide spectrum of pharmacological activities. It has been shown to exhibit anti-oxidant and anti-inflammatory properties, and is being used as herbal remedy since ancient times. Osteoarthritis of knee (KOA) is a chronic painful disorder in which prolong use of non-steroidal anti-inflammatory drugs (NSAIDs) or steroids may result into many serious side effects; hence, there is a need to develop herbal drugs, having good analgesia without side effects. Therefore, we planned to evaluate the efficacy of CL in KOA.

Methods

The study was designed as a randomized, double-blind, placebo-controlled trial in patients of KOA. After obtaining ethical clearance and written informed consent, a total of 160 patients of KOA were randomly enrolled into two groups to receive either CL extract or placebo along with the standard drug regimen. The patients were assessed on day 0, day 60, and day 120. On the days of their visit, the clinical prognosis was assessed by visual analog scale (VAS) and Western Ontario and McMaster Universities (WOMAC) Osteoarthritis index. On these days, the radiographs were also taken for Kellgren and Lawrence grading and blood samples were collected for assessing the changes in levels of IL-1β and biomarkers of oxidative stress, such as reactive oxygen species and malondialdehyde (MDA).

Results

Over all significant improvement was observed in the patients of CL extract group as compared to placebo group. Clinically, the VAS and WOMAC scores became better, and simultaneously, the levels of biomarkers, viz., IL-1β, ROS, and MDA, were also significantly (p < 0.05) improved.

Conclusion

It may be concluded that on chronic administration, CL suppresses inflammation and brings clinical improvement in patients of KOA, which may be observed by decreased level of IL-1β and VAS/WOMAC scores, respectively. At the same time, CL decreases the oxidative stress also.

Keywords

Osteoarthritis of knee Curcuma longa L. WOMAC Inflammatory biomarkers 

Notes

Acknowledgments

We are thankful to COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (CSIR), India for providing Senior Research Fellowship to MR. SHOBHIT SRIVASTAVA vide file no. 09/910/0006/2012-EMR-I for the study. Our sincere thanks to The Himalaya Drug Company, Bangalore, India for providing capsules of CL extract and placebo for the study. We are also thankful to Dr. A.K.S. Rawat, Scientist and Head, Department of Pharmacognosy and Ethnopharmacology, CSIR-National Botanical Research Institute, Lucknow for carrying out the finger print analysis of the CL extract capsules.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. Allen KD, Chen JC, Callahan LF, Golightly YM, Helmick CG, Renner JB, Jordan JM (2010) Associations of occupational tasks with knee and hip osteoarthritis: the Johnston County Osteoarthritis Project. J Rheumatol 37(4):842–850CrossRefPubMedPubMedCentralGoogle Scholar
  2. Altman RD, Marcussen KC (2001) Effects of a ginger extract on knee pain in patients with osteoarthritis. Arthr Rheum 44:2531–2538. doi: 10.1002/1529-0131(200111)44:11<2531:AID-ART433>3.0.CO;2-J CrossRefGoogle Scholar
  3. Altman R, Alarcón G, Appelrouth D, Bloch D, Borenstein D, Brandt K (1991) The American College of Rheumatology criteria for the classification and reporting of osteoarthritis of the hip. Arthr Rheum 34:505–514CrossRefGoogle Scholar
  4. Ambrosia RD (2005) Epidemiology of osteoarthritis. Orthopedics 28:S201–S205PubMedGoogle Scholar
  5. Amico D, Spadoni T, Rovinelli M, Serafini M, D’Amico G, Campelli N, Baroni SS, Gabrielli A (2015) Intracellular free radical production by peripheral blood T lymphocytes from patients with systemic sclerosis: role of NADPH oxidase and ERK1/2. Arthr Res Ther 17:68. doi: 10.1186/s13075-015-0591-8 CrossRefGoogle Scholar
  6. Attur M, Statnikov A, Samuels J, Li Z et al (2015) Plasma levels of interleukin-1 receptor antagonist (IL1Ra) predict radiographic progression of symptomatic knee osteoarthritis. Osteoarthr Cartil 23(11):1915–1924CrossRefPubMedPubMedCentralGoogle Scholar
  7. Barron MC, Rubin BR (2007) Managing osteoarthritic knee pain. J Am Osteopath Assoc 107:21–27Google Scholar
  8. Belcaro G, Cesarone MR, Dugall M, Pellegrini L, Ledda A, Grossi MG, Togni S, Appendino G (2010) Efficacy and safety of Meriva, a curcumin-phosphatidylcholine complex, during extended administration in osteoarthritis patients. Altern Med Rev 15:337–343PubMedGoogle Scholar
  9. Bellamy N, Buchanan WW, Goldsmith CH, Campbell J, Stitt LW (1988) Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to anti-rheumatic drug therapy inpatients with osteoarthritis of the hip or knee. J Rheumatol 15:1833–1840PubMedGoogle Scholar
  10. Bhatia D, Bejarano T, Novo M (2013) Current interventions in the management of knee osteoarthritis. J Pharm Bioallied Sci 5:30–38. doi: 10.4103/0975-7406.106561 CrossRefPubMedPubMedCentralGoogle Scholar
  11. Bjordal JM, Ljunggren AE, Klovning A, Slordal L (2004) Non-steroidal anti-inflammatory drugs, including cyclo-oxygenase-2 inhibitors, in osteoarthritic knee pain: meta-analysis of randomised placebo controlled trials. BMJ 329(7478):1317. doi: 10.1136/bmj.38273.626655.63 CrossRefPubMedPubMedCentralGoogle Scholar
  12. Boldyrev AA (2000) Discrimination between apoptosis and necrosis of neurons under oxidative stress. Biochemistry 65:834–842PubMedGoogle Scholar
  13. Burckhardt CS, Jones KD (2003) Adult measures of pain: The McGill Pain Questionnaire (MPQ), Rheumatoid Arthritis Pain Scale (RAPS), Short-Form McGill Pain Questionnaire (SF-MPQ), Verbal Descriptive Scale (VDS), Visual Analog Scale (VAS), and West Haven-Yale Multidisciplinary Pain Inventory (WHYMPI). Arthr Care Rheum 49:96–104CrossRefGoogle Scholar
  14. Chandra D, Gupta SS (1972) Anti-inflammatory and anti-arthritic activity of volatile oil of Curcuma longa (Haldi). Indian J Med Res 60:138–142PubMedGoogle Scholar
  15. Cross M, Smith E, Hoy D, Nolte S, Ackerman I, Fransen M, Bridgett L, Williams S, Guillemin F, Hill CL, Laslett LL, Jones G, Cicuttini F, Osborne R, Vos T, Buchbinder R, Woolf A, March L (2014) The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis 73(7):1323–1330CrossRefPubMedGoogle Scholar
  16. Cushnaghan J, Dieppe P (1991) Study of 500 patients with limb joint osteoarthritis. Analysis by age, sex, and distribution of symptomatic joint sites. Ann Rheum Dis 50:8–13CrossRefPubMedPubMedCentralGoogle Scholar
  17. Das SK, Farooqi A (2008) Osteoarthritis. Best Pract Res Clin Rheumatol 22:657–675. doi: 10.1016/j.berh.2008.07.002 CrossRefPubMedGoogle Scholar
  18. Dharmananda S (1998) Countering side effects of modern medical therapies with Chinese herbs. Institute for Traditional Medicine, PortlandGoogle Scholar
  19. Esser S, Bailey A (2011) Effects of exercise and physical activity on knee osteoarthritis. Curr Pain Headache Rep 15:423–430CrossRefPubMedGoogle Scholar
  20. Goldring MB, Otero M (2011) Inflammation in osteoarthritis. Curr Opin Rheumatol 23:471–478CrossRefPubMedPubMedCentralGoogle Scholar
  21. Harma M, Erel O (2003) Increased oxidative stress in patients with hydatidiform mole. Swiss Med Wkly 133:563–566PubMedGoogle Scholar
  22. Ji Q, Xu X, Zhang Q, Kang L, Xu Y, Zhang K, Li L, Liang Y, Hong T, Ye Q, Wang Y (2016) The IL-1beta/AP-1/miR-30a/ADAMTS-5 axis regulates cartilage matrix degradation in human osteoarthritis. J Mol Med (Berl) 94(7):771–785. doi: 10.1007/s00109-016-1418-z CrossRefGoogle Scholar
  23. Jurenka JS (2009) Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: a review of preclinical and clinical research. Altern Med Rev 14:141–153PubMedGoogle Scholar
  24. Kaviratna AC, Sharma P (1913) The Charaka Samhita 5 Vols., Sri Satguru, ISBN81-7030. pp 471–477Google Scholar
  25. Kellgren JH, Lawrence JS (1957) Radiological assessment of osteo-arthrosis. Ann Rheum Dis 16:494–502CrossRefPubMedPubMedCentralGoogle Scholar
  26. Kuptniratsaikul V, Dajpratham P, Taechaarpornkul W, Buntragulpoontawee M, Lukkanapichonchut P, Chootip C, Saengsuwan J, Tantayakom K, Laongpech S (2014) Efficacy and safety of Curcuma domestica extracts compared with ibuprofen in patients with knee osteoarthritis: a multicenter study. Clin Interv Aging 9:451–458. doi: 10.2147/CIA.S58535 CrossRefPubMedPubMedCentralGoogle Scholar
  27. Lopaczynski W, Zeisel SH (2001) Antioxidants, programmed cell death and cancer. Nutr Res 21:295–307CrossRefGoogle Scholar
  28. Madhu K, Chandan K, Saji MJ (2013) Safety and efficacy of Curcuma longa extract in the treatment of painful knee osteoarthritis: a randomized placebo-controlled trial. Inflammopharmacology 21:129–136. doi: 10.1007/s10787-012-0163-3 CrossRefPubMedGoogle Scholar
  29. Martin JA, Brown TD, Heiner AD et al (2004) Chondrocyte senescence, joint loading and osteoarthritis. Clin Orthop Relat Res 427:S96–S103CrossRefGoogle Scholar
  30. Mateen S, Moin S, Khan AQ, Zafar A, Fatima N (2016) Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis. PLoS One 11(4):e0152925. doi: 10.1371/journal.pone.015292 CrossRefPubMedPubMedCentralGoogle Scholar
  31. Michael JW, Schlüter-Brust KU, Eysel P (2010) The epidemiology, etiology, diagnosis, and treatment of osteoarthritis of the knee. Dtsch Arztebl Int 107:152–162. doi: 10.3238/arztebl.2010.0152 PubMedPubMedCentralGoogle Scholar
  32. Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20(7):1126–1167CrossRefPubMedPubMedCentralGoogle Scholar
  33. Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340:c869. doi: 10.1136/bmj.c869 CrossRefPubMedPubMedCentralGoogle Scholar
  34. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358CrossRefPubMedGoogle Scholar
  35. Paliwal MN, Sontakke AN, Paliwal P (2012) Study of enzymatic antioxidant marker and lipid peroxidation status in patients with osteoarthritis. J Evol Med Dent Sci 1:634–638CrossRefGoogle Scholar
  36. Pinsornsak P, Niempoog S (2012) The efficacy of Curcuma Longa L. extract as an adjuvant therapy in primary knee osteoarthritis: a randomized control trial. J Med Assoc Thail 95(Supp 1):S51–S58Google Scholar
  37. Roth G, Chandra A, Nair M (1998) Novel bioactivities of Curcuma longa constituents. J Nat Prod 61:542–545CrossRefPubMedGoogle Scholar
  38. Sarkar M, Varshney R, Chopra M, Sekhri T, Adhikari JS, Dwarakanath BS (2005) Flow-cytometric analysis of reactive oxygen species in peripheral blood mononuclear cells of patients with thyroid dysfunction. Cytom B Clin Cytom 70:20–23Google Scholar
  39. Scartezzini P, Speroni E (2000) Review on some plants of Indian traditional medicine with antioxidant activity. J Ethnopharmacol 71:23–43CrossRefPubMedGoogle Scholar
  40. Selvam R, Subramanian L, Gayathri R, Angayarkanni N (1995) The anti-oxidant activity of turmeric (Curcuma longa). J Ethnopharmacol 47:59–67CrossRefPubMedGoogle Scholar
  41. Shahine EM, Elhadidi AS (2014) Efficacy of glucosamine sulfate in lowering serum level of interleukin-1β in symptomatic primary knee osteoarthritis: Clinical and laboratory study. Alex J Med 50(2):159–163CrossRefGoogle Scholar
  42. Sharma OP (1976) Antioxidant activity of curcumin and related compounds. Biochem Pharmacol 25(15):1811–1812CrossRefPubMedGoogle Scholar
  43. Srivastava S, Saksena AK, Khattri S, Kumar S, Dagur RS (2015) Status of oxidative stress biomarkers in osteoarthritis patients in North Indian population. Osteoarthr Cartil 23:A84–A85. doi: 10.1016/j.joca.2015.02.785 CrossRefGoogle Scholar
  44. The Ayurvedic Pharmacopoeia of India (1989) Part I, Department of AYUSH, Ministry of Health and Family Welfare, Govt. of IndiaGoogle Scholar
  45. Verma P, Dalal K (2013) Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker. J Orthop Res 31(7):999–1006. doi: 10.1002/jor.22324 CrossRefPubMedGoogle Scholar
  46. Wade CR, van Rij AM (1988) Plasma thiobarbituric acid reactivity: reaction conditions and the role of iron, antioxidants and lipid peroxy radicals on the quantitation of plasma lipid peroxides. Life Sci 43:1085–1093CrossRefPubMedGoogle Scholar
  47. Wang CT, Lin J, Chang CJ, Lin YT, Hou SM (2004) Therapeutic effects of hyaluronic acid on osteoarthritis of the knee. A meta-analysis of randomized controlled trials. J Bone Jt Surg 86:538–545CrossRefGoogle Scholar
  48. Yudoh K, Nguyen T, Nakamura H et al (2005) Potential involvement of oxidative stress in cartilage senescence and development of osteoarthritis: oxidative stress induces chondrocyte telomere instability and down regulation of chondrocyte function. Arthr Res Ther 7(2):R380–R391CrossRefGoogle Scholar

Copyright information

© Springer International Publishing 2016

Authors and Affiliations

  • Shobhit Srivastava
    • 1
  • Anil K. Saksena
    • 1
    Email author
  • Sanjay Khattri
    • 1
  • Santosh Kumar
    • 2
  • Raghubendra Singh Dagur
    • 3
  1. 1.Department of Pharmacology and TherapeuticsKing George’s Medical UniversityLucknowIndia
  2. 2.Department of Orthopaedic SurgeryKing George’s Medical UniversityLucknowIndia
  3. 3.Centre for Advance ResearchKing George’s Medical UniversityLucknowIndia

Personalised recommendations